Published in Biochim Biophys Acta on February 09, 2001
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat Biotechnol (2008) 6.81
Rational design of cationic lipids for siRNA delivery. Nat Biotechnol (2010) 4.97
Development of lipidoid-siRNA formulations for systemic delivery to the liver. Mol Ther (2009) 2.39
Spontaneous entrapment of polynucleotides upon electrostatic interaction with ethanol-destabilized cationic liposomes. Biophys J (2001) 1.64
Lipidic systems for in vivo siRNA delivery. AAPS J (2009) 1.33
Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics. J Pharm Sci (2011) 1.24
Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells. Mol Ther (2011) 1.23
Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA. Mol Ther Nucleic Acids (2012) 1.16
Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system. Int J Nanomedicine (2012) 1.09
A method to co-encapsulate gas and drugs in liposomes for ultrasound-controlled drug delivery. Ultrasound Med Biol (2008) 1.09
Influence of Polyethylene Glycol Lipid Desorption Rates on Pharmacokinetics and Pharmacodynamics of siRNA Lipid Nanoparticles. Mol Ther Nucleic Acids (2013) 1.05
Preparation and in-vitro Evaluation of an Antisense-containing Cationic Liposome against Non-small Cell Lung Cancer: a Comparative Preparation Study. Iran J Pharm Res (2013) 1.02
Enhanced detergent extraction for analysis of membrane proteomes by two-dimensional gel electrophoresis. Proteome Sci (2005) 1.00
In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myeloma. PLoS One (2014) 1.00
Transferrin-conjugated SNALPs encapsulating 2'-O-methylated miR-34a for the treatment of multiple myeloma. Biomed Res Int (2014) 0.94
Tumor-targeted Chlorotoxin-coupled Nanoparticles for Nucleic Acid Delivery to Glioblastoma Cells: A Promising System for Glioblastoma Treatment. Mol Ther Nucleic Acids (2013) 0.94
Lipid Nanoparticles Containing siRNA Synthesized by Microfluidic Mixing Exhibit an Electron-Dense Nanostructured Core. J Phys Chem C Nanomater Interfaces (2012) 0.93
Molecular and cellular barriers limiting the effectiveness of antisense oligonucleotides. Biophys J (2005) 0.91
Antitumor activity of G3139 lipid nanoparticles (LNPs). Mol Pharm (2009) 0.88
Inhibiting metastatic breast cancer cell migration via the synergy of targeted, pH-triggered siRNA delivery and chemokine axis blockade. Mol Pharm (2014) 0.87
Delivery of oligonucleotides with lipid nanoparticles. Adv Drug Deliv Rev (2015) 0.87
Advances in Lipid Nanoparticles for siRNA Delivery. Pharmaceutics (2013) 0.85
Shielding of Lipid Nanoparticles for siRNA Delivery: Impact on Physicochemical Properties, Cytokine Induction, and Efficacy. Mol Ther Nucleic Acids (2014) 0.84
Microfluidic assembly of lipid-based oligonucleotide nanoparticles. Anticancer Res (2011) 0.82
Targeted delivery of nucleic-acid-based therapeutics to the pulmonary circulation. AAPS J (2009) 0.80
Next generation delivery system for proteins and genes of therapeutic purpose: why and how? Biomed Res Int (2014) 0.79
Conjugation of lipid and CpG-containing oligonucleotide yields an efficient method for liposome incorporation. Bioconjug Chem (2011) 0.79
Lipid Nanoparticle Systems for Enabling Gene Therapies. Mol Ther (2017) 0.77
An ion switch regulates fusion of charged membranes. Biophys J (2011) 0.76
Surface-mediated nucleic acid delivery by lipoplexes prepared in microwell arrays. Small (2013) 0.75
Bladder cancer: Micro RNAs as biomolecules for prognostication and surveillance. Indian J Urol (2017) 0.75
Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice. BMC Res Notes (2017) 0.75
Aerosol Delivery of siRNA to the Lungs. Part 2: Nanocarrier-based Delivery Systems. Kona (2016) 0.75
Lipid Nanovectors to Deliver RNA Oligonucleotides in Cancer. Nanomaterials (Basel) (2016) 0.75
In vitro detection of mdr1 mRNA in murine leukemia cells with 111In-labeled oligonucleotide. Eur J Nucl Med Mol Imaging (2004) 0.75
Vesicles of variable sizes produced by a rapid extrusion procedure. Biochim Biophys Acta (1986) 7.07
Lipid polymorphism and the functional roles of lipids in biological membranes. Biochim Biophys Acta (1979) 5.39
Single-particle electron cryo-microscopy: towards atomic resolution. Q Rev Biophys (2000) 4.86
Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size distribution, trapped volume and ability to maintain a membrane potential. Biochim Biophys Acta (1985) 4.47
Pathology of fatal human infection associated with avian influenza A H5N1 virus. J Med Virol (2001) 4.08
Osmotic properties of large unilamellar vesicles prepared by extrusion. Biophys J (1993) 3.11
X-ray diffraction study of the polymorphic behavior of N-methylated dioleoylphosphatidylethanolamine. Biochemistry (1988) 2.75
Regulation of phosphoenolpyruvate carboxylase of Zea mays by metabolites. Biochem J (1973) 2.37
Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood (1997) 2.36
On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids. Gene Ther (2001) 2.35
Smoothed orientational order profile of lipid bilayers by 2H-nuclear magnetic resonance. Biophys J (1989) 2.33
Unusual lipid structures selectively reduce the toxicity of amphotericin B. Proc Natl Acad Sci U S A (1988) 2.22
Expression and modulation of CD44 variant isoforms in humans. J Cell Biol (1994) 2.17
Lipid polymorphism: the molecular basis of nonbilayer phases. Annu Rev Biophys Biophys Chem (1985) 2.14
Solute distributions and trapping efficiencies observed in freeze-thawed multilamellar vesicles. Biochim Biophys Acta (1985) 2.05
Reconstruction of the ulnar collateral ligament in athletes. J Bone Joint Surg Am (1986) 2.05
A standarized test of renal concentrating capacity in children. Am J Dis Child (1967) 1.96
Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I study. Leukemia (2011) 1.92
The Sm domain is an ancient RNA-binding motif with oligo(U) specificity. Proc Natl Acad Sci U S A (2001) 1.81
A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma. Leukemia (2010) 1.81
Early medical use of cannabis. Nature (1993) 1.80
Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular lymphomas. Leukemia (2007) 1.79
Rapid long-range proton diffusion along the surface of the purple membrane and delayed proton transfer into the bulk. Proc Natl Acad Sci U S A (1995) 1.77
Advantages of CCD detectors for de novo three-dimensional structure determination in single-particle electron microscopy. J Struct Biol (2005) 1.75
Effects of fusogenic agent on membrane structure of erythrocyte ghosts and the mechanism of membrane fusion. Nature (1978) 1.74
Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma. Blood (2001) 1.74
The polymorphic phase behaviour of phosphatidylethanolamines of natural and synthetic origin. A 31P NMR study. Biochim Biophys Acta (1978) 1.73
Acyl chain orientational order in the hexagonal HII phase of phospholipid-water dispersions. Biophys J (1988) 1.68
Color discrimination in halobacteria: spectroscopic characterization of a second sensory receptor covering the blue-green region of the spectrum. Proc Natl Acad Sci U S A (1986) 1.65
Spontaneous entrapment of polynucleotides upon electrostatic interaction with ethanol-destabilized cationic liposomes. Biophys J (2001) 1.64
Influence of transbilayer area asymmetry on the morphology of large unilamellar vesicles. Biophys J (1995) 1.64
Lipid polymorphism and the roles of lipids in membranes. Chem Phys Lipids (1986) 1.64
Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes. J Biol Chem (1992) 1.63
Modulation of the orientational order profile of the lipid acyl chain in the L alpha phase. Eur Biophys J (1990) 1.60
High constitutive activity of native H3 receptors regulates histamine neurons in brain. Nature (2000) 1.60
Proton movement on membranes. Nature (1995) 1.54
Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol). Biosci Rep (2002) 1.53
Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient. Biochim Biophys Acta (1986) 1.52
A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma. Leukemia (2005) 1.51
GTPases mechanisms and functions of translation factors on the ribosome. Biol Chem (2000) 1.51
The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma. Leukemia (2011) 1.50
Protection of large unilamellar vesicles by trehalose during dehydration: retention of vesicle contents. Biochim Biophys Acta (1985) 1.49
Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. Cancer Res (1989) 1.47
Cytochrome c specifically induces non-bilayer structures in cardiolipin-containing model membranes. Biochim Biophys Acta (1980) 1.47
Penicillium marneffei Infection in AIDS. Patholog Res Int (2011) 1.44
Detection of t(2;5) in anaplastic large cell lymphoma: comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue. Am J Surg Pathol (1999) 1.43
Bowel perforation in intestinal lymphoma: incidence and clinical features. Ann Oncol (2013) 1.41
AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma. Oncogene (2010) 1.40
Idiopathic hypercalciuria. Pediatr Nephrol (1991) 1.39
Phospholipid asymmetry in large unilamellar vesicles induced by transmembrane pH gradients. Biochemistry (1989) 1.39
Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist. J Pharmacol Exp Ther (1998) 1.38
Automatic CTF correction for single particles based upon multivariate statistical analysis of individual power spectra. J Struct Biol (2003) 1.37
The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes. J Immunol (1991) 1.34
Stabilized plasmid-lipid particles: construction and characterization. Gene Ther (1999) 1.33
Three-dimensional structure of the anaphase-promoting complex. Mol Cell (2001) 1.31
The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey. Chem Phys Lipids (1990) 1.31
Frequency dependence of 31P NMR linewidths in sonicated phospholipid vesicles: effects of chemical shift anisotropy. FEBS Lett (1974) 1.27
Corrim-based alignment for improved speed in single-particle image processing. J Struct Biol (2003) 1.26
Modulation of membrane fusion by asymmetric transbilayer distributions of amino lipids. Biochemistry (1994) 1.26
Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate. Bone Marrow Transplant (2004) 1.26
Developments in liposomal drug delivery systems. Expert Opin Biol Ther (2001) 1.25
Structural and fusogenic properties of cationic liposomes in the presence of plasmid DNA. Biophys J (1997) 1.25
Influence of cholesterol on the structural preferences of dioleoylphosphatidylethanolamine-dioleoylphosphatidylcholine systems: a phosphorus-31 and deuterium nuclear magnetic resonance study. Biochemistry (1982) 1.25
Use of liposomes as injectable-drug delivery systems. Am J Hosp Pharm (1989) 1.24
Comparison of the orientational order of lipid chains in the L alpha and HII phases. Biochemistry (1990) 1.23
Factors affecting the motion of the polar headgroup in phospholipid bilayers. A 31P NMR study of unsonicated phosphatidylcholine liposomes. Biochim Biophys Acta (1976) 1.22
Polymorphic phase behaviour of lipid mixtures as detected by 31P NMR. Evidence that cholesterol may destabilize bilayer structure in membrane systems containing phosphatidylethanolamine. Biochim Biophys Acta (1978) 1.22
Antibacterial efficacy against an in vivo Salmonella typhimurium infection model and pharmacokinetics of a liposomal ciprofloxacin formulation. Antimicrob Agents Chemother (1998) 1.21
Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients. Biochim Biophys Acta (1990) 1.21
Poly(ethylene glycol)--lipid conjugates regulate the calcium-induced fusion of liposomes composed of phosphatidylethanolamine and phosphatidylserine. Biochemistry (1996) 1.20
A morpho-molecular prognostic model for hepatocellular carcinoma. Br J Cancer (2012) 1.20
Fluid transport at low Reynolds number with magnetically actuated artificial cilia. Eur Phys J E Soft Matter (2009) 1.20
Functions of DNA polymerases alpha, beta, and gamma in neurons during development. Cold Spring Harb Symp Quant Biol (1979) 1.20
A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma. Br J Cancer (2010) 1.19
Roles of lipid polymorphism in intracellular delivery. Adv Drug Deliv Rev (2001) 1.19
Application of 31P NMR to model and biological membrane systems. FEBS Lett (1975) 1.19
Techniques for encapsulating bioactive agents into liposomes. Chem Phys Lipids (1986) 1.18
Surface charge of bacteriorhodopsin detected with covalently bound pH indicators at selected extracellular and cytoplasmic sites. Biochemistry (1994) 1.18
Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane potential. Biochim Biophys Acta (1985) 1.18
On the mechanism of transbilayer transport of phosphatidylglycerol in response to transmembrane pH gradients. Biochemistry (1990) 1.18
Transbilayer transport of phosphatidic acid in response to transmembrane pH gradients. Biochemistry (1991) 1.17